2018 Symposium on Cancer Evolution and Heterogeneity
Heterogeneity is a major challenge in Cancer treatment, which has a profound impact on Cancer evolution & metastasis and drug resistance. With the developments of new technologies, there emerge successive achievements with great significance on clinical therapeutics. This symposium will focus on Cancer heterogeneity, promoting the clinical translation of research.
2018 Symposium on Tumor Microenvironment and Cancer Immunotherapy
With the approval of many PD-1 checkpoint inhibitors and the success of lots of clinical trials on Cancer immunotherapy, people become more confident with overwhelming the incurable disease. However, there still remain unsolved problems in tumor microenvironment & tumor immunity.
2018 Symposium on Cancer MDT and LDT
Treatment of Cancer depend on not only one discipline, but also cooperation among several departments, including tumor, imaging and pathology department. Cancer MDT is more important for patients at immediate and advanced stages. With the rapid progress of new technologies, LDT is playing a key role in early tumor diagnosis.